 |
Somatropin |
|---|---|
| Trade Name | Norditropin |
| Orphan Indication | Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures |
| USA Market Approval | USA |
| USA Designation Date | 1987-09-01 00:00:00 |
| Sponsor | Novo Nordisk Pharmaceuticals;100 Overlook Center, Suite 200;Princeton, New Jersey, 08540 |
